Rhythmic, vocal and body-based musical training to support thinking and social skills in schizophrenia
Official title: Multicenter Study Evaluating the Efficacy of a Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia Patients
Run by University Hospital, Toulouse · NCT07055204 · Data updated 2026-11-12
This trial tests whether a 6-month group musical program using rhythm, singing and movement can help adults with schizophrenia improve attention and negative symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 6 sites (Bayonne and 5 other locations) |
| Status | Recruiting |
| Started | October 21, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT07055204 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults diagnosed with schizophrenia or schizoaffective disorder who are clinically stable, in regular psychiatric follow-up, enrolled in at least one out-of-home therapeutic or social activity, on no medication changes for 3 months, and able to give informed consent are eligible.
✕Probably not a fit
Patients with moderate to severe intellectual disability, active addictive comorbidity (excluding tobacco and behavioral addictions), neurological disorders with cognitive impact, those already engaged in rhythmic or musical activities, or those currently in a neurocognitive remediation program are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a national, multicenter, randomized open-label trial comparing a 6-month collective embodied musical learning program to standard care for people with schizophrenia. Participants are randomized to weekly one-hour group sessions (24 sessions total) led by trained music teachers or to continue standard care, with groups of about 10 patients per site. Outcomes focus on attentional deficits, cognitive domains such as working memory and executive function, and negative symptoms, with visits at baseline, 3, 6 and 9 months. A 3-month post-intervention follow-up evaluates whether any benefits persist after the sessions end.
Why it matters
Potential benefit: If successful, the program could improve attention, working memory and negative symptoms, which may translate into better daily functioning and social participation.
How similar studies have gone: Music-based interventions have shown cognitive and social benefits in general populations and some clinical samples, but few randomized trials have tested this specific collective embodied musical learning approach in schizophrenia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with a diagnosis of schizophrenia or schizoaffective disorder (DSM-5 TR criteria) * Clinically stable (no full-time hospitalization related to schizophrenia for 3 months) * Regular psychiatric follow-up * Enrolled in at least 1 therapeutic or social out-of-home activity * No change in the antipsychotic treatment for 3 months (medication and/or dosage) * Have given free, informed and written consent to participate in the study. * Patient affiliated or beneficiary of a social security scheme Exclusion Criteria: * Patient with moderate to severe intellectual disability (clinical criteria) * Engaged in a Social rythmic or musical activity * Presenting an addictive comorbidity (excluding tobacco addiction and behavioural addictions) * Presenting a neurological pathology with cognitive impact * Involved in a neurocognitive remediation program
Where it's running
-
CH de la Côte Basque
Bayonne, France Recruiting -
CH Le Vinatier
Bron, France Recruiting -
Association route nouvelle
Toulouse, France Recruiting -
Centre de Santé MGEN
Toulouse, France Recruiting -
CH Gérard Marchant
Toulouse, France Recruiting -
Assistance Publique Hôpitaux de Marseille
Marseille, France Not yet recruiting
Study contacts
- Study coordinator: Soukaina Chouiba
- Email: soukaina.chouiba@ferrepsy.fr
- Phone: 05 61 43 78 63
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transition Support for First-Episode Psychosis
A team-based program helps people experiencing their first psychotic episode move from hospital to outpatient care to see if they stay engaged and feel better.
-
SEEG-guided DBS for Schizophrenia
This study tests whether SEEG-guided deep brain stimulation can help people with treatment-resistant schizophrenia see if symptoms improve.
-
Using an epigenetic drug to boost virtual reality cognitive training for middle-aged and older adults with depression or bipolar disorder
This trial will test whether daily sodium butyrate combined with three weeks of virtual reality cognitive training improves thinking skills in symptomatically stable adults aged 40–75 with depression or bipolar disorder.
-
Medical and psychiatric profiling of adults admitted to general adult psychiatry wards
This project will collect questionnaires, rating scales, and case-note information from adults admitted to general adult psychiatry wards to see what their physical and mental health profiles look like.
-
iTEST: a blended mobile program to improve introspective accuracy (accurate self-judgment of abilities)
This trial tests whether iTEST — daily mobile cognitive training plus coaching that focuses on accurate self-judgment — helps adults with schizophrenia-spectrum or other psychotic disorders improve community functioning.
-
VR avatar therapy for psychosis: linking thinking, self-awareness, and social cognition
This project will test whether cognitive, metacognitive, and social-cognition factors relate to how well VR-based avatar therapy helps people with schizophrenia who have persistent auditory hallucinations.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.